Clinical Trial Update: Montreal Immune-Related Adverse Events (MIRAE) Study

View source ↗

Summary

The MIRAE study in Montreal is an ongoing clinical trial investigating immune-related adverse events in cancer patients, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• Cancer
• Inflammatory Diseases

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Cancer, Immune System Disorder | Status: RECRUITING